Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ACESION PHARMA ApS
APS
Active
Advertising protection
CVR 34083738
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
16 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ACESION PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
US
Ulrik Svane Sørensen
Founder
Founder
2011
AG
Anders Gaarsdal Holst
Chief Executive Officer
Chief Executive Officer
2022
MG
Morten Grunnet
Founder
Founder
2011
Former (3)
FG
Frans Gustaf Wuite
Chief Executive Officer
Chief Executive Officer
2016 – 2020
JD
Jakob Dynnes Hansen
Management
Management
2017 – 2018
TV
Torgeir Vaage
Management
Management
2018 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
JS
Jørgen Søberg Petersen
Chairman
Chairman
2020
TM
Timothy Michael Shannon
Board of Directors
Board of Directors
2023
BB
Benjamin Bruno Thorner
Board of Directors
Board of Directors
2024
NE
Nik Economopoulos
Board of Directors
Board of Directors
2023
Former (12)
BG
Bobby G Soni
Board of Directors
Board of Directors
2014 – 2015
AM
Ann Mills-Duggan
Board of Directors
Board of Directors
2018 – 2022
KJ
Karen Juo-Lai Chu
Board of Directors
Board of Directors
2019 – 2023
MD
Morten Døssing
Board of Directors
Board of Directors
2019 – 2023
DX
Duan Xiang
Board of Directors
Board of Directors
2019 – 2019
PD
Paul David Goldenheim
Board of Directors
Board of Directors
2016 – 2020
IS
Ingelise Saunders
Chairman
Chairman
2014 – 2020
SC
Stephan Christgau
Board of Directors
Board of Directors
2015 – 2019
FK
Frank Knudsen
Board of Directors
Board of Directors
2011 – 2014
GT
Georgios Trichas
Board of Directors
Board of Directors
2017 – 2018
CS
Carsten Schou
Board of Directors
Board of Directors
2014 – 2016
LG
Lars Gredsted
Board of Directors
Board of Directors
2017 – 2017
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Novo Holdings A/S
Company
33.33–49.99%
33.33–49.99%
2025
Canaan XII L.P.
Individual
20–24.99%
20–24.99%
2025
Alpha Wave Ventures II, LP
Individual
15–19.99%
15–19.99%
2025
RMG-KB BioAccess Fund, L.P.
Individual
5–9.99%
5–9.99%
2025
The Wellcome Trust Limited as trustee of the Wellcome Trust
Individual
5–9.99%
5–9.99%
2022
Uddannelses- og Forskningsstyrelsen
Company
5–9.99%
5–9.99%
2016
FC Danishbio Holdings Limited
Individual
5–9.99%
5–9.99%
2021
Broadview Ventures I LLC
Individual
5–9.99%
5–9.99%
2019
FC Inbio Holdings Limited
Individual
5–9.99%
5–9.99%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ACESION PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network